Abstract
Summary
LPI (LP Information)' newest research report, the “Non-Clinical Testing Service Industry Forecast” looks at past sales and reviews total world Non-Clinical Testing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Clinical Testing Service sales for 2023 through 2029. With Non-Clinical Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Clinical Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Non-Clinical Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Clinical Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Clinical Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Clinical Testing Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Clinical Testing Service.
The global Non-Clinical Testing Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Clinical Testing Service players cover UL Solutions, NAMSA, CMIC, VelaLabs, Unilab Clinical Laboratory, ERBC Group, STILLMEADOW, Eurofins SFA and Dayton T. Brown, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Clinical Testing Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pharmacological Test
Toxicity Test
Segmentation by application
Medicine
Medical Instruments
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UL Solutions
NAMSA
CMIC
VelaLabs
Unilab Clinical Laboratory
ERBC Group
STILLMEADOW
Eurofins SFA
Dayton T. Brown
Alliance Technologies
Geotechnics
Elemental Analysis
ImmunoSite Technologies
Ascendant Engineering Solutions
This Insight Report provides a comprehensive analysis of the global Non-Clinical Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Clinical Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Clinical Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Clinical Testing Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Clinical Testing Service.
The global Non-Clinical Testing Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Clinical Testing Service players cover UL Solutions, NAMSA, CMIC, VelaLabs, Unilab Clinical Laboratory, ERBC Group, STILLMEADOW, Eurofins SFA and Dayton T. Brown, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Clinical Testing Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pharmacological Test
Toxicity Test
Segmentation by application
Medicine
Medical Instruments
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UL Solutions
NAMSA
CMIC
VelaLabs
Unilab Clinical Laboratory
ERBC Group
STILLMEADOW
Eurofins SFA
Dayton T. Brown
Alliance Technologies
Geotechnics
Elemental Analysis
ImmunoSite Technologies
Ascendant Engineering Solutions
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Clinical Testing Service Market Size 2018-2029
2.1.2 Non-Clinical Testing Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Non-Clinical Testing Service Segment by Type
2.2.1 Pharmacological Test
2.2.2 Toxicity Test
2.3 Non-Clinical Testing Service Market Size by Type
2.3.1 Non-Clinical Testing Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Non-Clinical Testing Service Market Size Market Share by Type (2018-2023)
2.4 Non-Clinical Testing Service Segment by Application
2.4.1 Medicine
2.4.2 Medical Instruments
2.5 Non-Clinical Testing Service Market Size by Application
2.5.1 Non-Clinical Testing Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Non-Clinical Testing Service Market Size Market Share by Application (2018-2023)
3 Non-Clinical Testing Service Market Size by Player
3.1 Non-Clinical Testing Service Market Size Market Share by Players
3.1.1 Global Non-Clinical Testing Service Revenue by Players (2018-2023)
3.1.2 Global Non-Clinical Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Non-Clinical Testing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-Clinical Testing Service by Regions
4.1 Non-Clinical Testing Service Market Size by Regions (2018-2023)
4.2 Americas Non-Clinical Testing Service Market Size Growth (2018-2023)
4.3 APAC Non-Clinical Testing Service Market Size Growth (2018-2023)
4.4 Europe Non-Clinical Testing Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Non-Clinical Testing Service Market Size Growth (2018-2023)
5 Americas
5.1 Americas Non-Clinical Testing Service Market Size by Country (2018-2023)
5.2 Americas Non-Clinical Testing Service Market Size by Type (2018-2023)
5.3 Americas Non-Clinical Testing Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Clinical Testing Service Market Size by Region (2018-2023)
6.2 APAC Non-Clinical Testing Service Market Size by Type (2018-2023)
6.3 APAC Non-Clinical Testing Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-Clinical Testing Service by Country (2018-2023)
7.2 Europe Non-Clinical Testing Service Market Size by Type (2018-2023)
7.3 Europe Non-Clinical Testing Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Clinical Testing Service by Region (2018-2023)
8.2 Middle East & Africa Non-Clinical Testing Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Non-Clinical Testing Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-Clinical Testing Service Market Forecast
10.1 Global Non-Clinical Testing Service Forecast by Regions (2024-2029)
10.1.1 Global Non-Clinical Testing Service Forecast by Regions (2024-2029)
10.1.2 Americas Non-Clinical Testing Service Forecast
10.1.3 APAC Non-Clinical Testing Service Forecast
10.1.4 Europe Non-Clinical Testing Service Forecast
10.1.5 Middle East & Africa Non-Clinical Testing Service Forecast
10.2 Americas Non-Clinical Testing Service Forecast by Country (2024-2029)
10.2.1 United States Non-Clinical Testing Service Market Forecast
10.2.2 Canada Non-Clinical Testing Service Market Forecast
10.2.3 Mexico Non-Clinical Testing Service Market Forecast
10.2.4 Brazil Non-Clinical Testing Service Market Forecast
10.3 APAC Non-Clinical Testing Service Forecast by Region (2024-2029)
10.3.1 China Non-Clinical Testing Service Market Forecast
10.3.2 Japan Non-Clinical Testing Service Market Forecast
10.3.3 Korea Non-Clinical Testing Service Market Forecast
10.3.4 Southeast Asia Non-Clinical Testing Service Market Forecast
10.3.5 India Non-Clinical Testing Service Market Forecast
10.3.6 Australia Non-Clinical Testing Service Market Forecast
10.4 Europe Non-Clinical Testing Service Forecast by Country (2024-2029)
10.4.1 Germany Non-Clinical Testing Service Market Forecast
10.4.2 France Non-Clinical Testing Service Market Forecast
10.4.3 UK Non-Clinical Testing Service Market Forecast
10.4.4 Italy Non-Clinical Testing Service Market Forecast
10.4.5 Russia Non-Clinical Testing Service Market Forecast
10.5 Middle East & Africa Non-Clinical Testing Service Forecast by Region (2024-2029)
10.5.1 Egypt Non-Clinical Testing Service Market Forecast
10.5.2 South Africa Non-Clinical Testing Service Market Forecast
10.5.3 Israel Non-Clinical Testing Service Market Forecast
10.5.4 Turkey Non-Clinical Testing Service Market Forecast
10.5.5 GCC Countries Non-Clinical Testing Service Market Forecast
10.6 Global Non-Clinical Testing Service Forecast by Type (2024-2029)
10.7 Global Non-Clinical Testing Service Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 UL Solutions
11.1.1 UL Solutions Company Information
11.1.2 UL Solutions Non-Clinical Testing Service Product Offered
11.1.3 UL Solutions Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 UL Solutions Main Business Overview
11.1.5 UL Solutions Latest Developments
11.2 NAMSA
11.2.1 NAMSA Company Information
11.2.2 NAMSA Non-Clinical Testing Service Product Offered
11.2.3 NAMSA Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 NAMSA Main Business Overview
11.2.5 NAMSA Latest Developments
11.3 CMIC
11.3.1 CMIC Company Information
11.3.2 CMIC Non-Clinical Testing Service Product Offered
11.3.3 CMIC Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 CMIC Main Business Overview
11.3.5 CMIC Latest Developments
11.4 VelaLabs
11.4.1 VelaLabs Company Information
11.4.2 VelaLabs Non-Clinical Testing Service Product Offered
11.4.3 VelaLabs Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 VelaLabs Main Business Overview
11.4.5 VelaLabs Latest Developments
11.5 Unilab Clinical Laboratory
11.5.1 Unilab Clinical Laboratory Company Information
11.5.2 Unilab Clinical Laboratory Non-Clinical Testing Service Product Offered
11.5.3 Unilab Clinical Laboratory Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Unilab Clinical Laboratory Main Business Overview
11.5.5 Unilab Clinical Laboratory Latest Developments
11.6 ERBC Group
11.6.1 ERBC Group Company Information
11.6.2 ERBC Group Non-Clinical Testing Service Product Offered
11.6.3 ERBC Group Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ERBC Group Main Business Overview
11.6.5 ERBC Group Latest Developments
11.7 STILLMEADOW
11.7.1 STILLMEADOW Company Information
11.7.2 STILLMEADOW Non-Clinical Testing Service Product Offered
11.7.3 STILLMEADOW Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 STILLMEADOW Main Business Overview
11.7.5 STILLMEADOW Latest Developments
11.8 Eurofins SFA
11.8.1 Eurofins SFA Company Information
11.8.2 Eurofins SFA Non-Clinical Testing Service Product Offered
11.8.3 Eurofins SFA Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Eurofins SFA Main Business Overview
11.8.5 Eurofins SFA Latest Developments
11.9 Dayton T. Brown
11.9.1 Dayton T. Brown Company Information
11.9.2 Dayton T. Brown Non-Clinical Testing Service Product Offered
11.9.3 Dayton T. Brown Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Dayton T. Brown Main Business Overview
11.9.5 Dayton T. Brown Latest Developments
11.10 Alliance Technologies
11.10.1 Alliance Technologies Company Information
11.10.2 Alliance Technologies Non-Clinical Testing Service Product Offered
11.10.3 Alliance Technologies Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Alliance Technologies Main Business Overview
11.10.5 Alliance Technologies Latest Developments
11.11 Geotechnics
11.11.1 Geotechnics Company Information
11.11.2 Geotechnics Non-Clinical Testing Service Product Offered
11.11.3 Geotechnics Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Geotechnics Main Business Overview
11.11.5 Geotechnics Latest Developments
11.12 Elemental Analysis
11.12.1 Elemental Analysis Company Information
11.12.2 Elemental Analysis Non-Clinical Testing Service Product Offered
11.12.3 Elemental Analysis Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Elemental Analysis Main Business Overview
11.12.5 Elemental Analysis Latest Developments
11.13 ImmunoSite Technologies
11.13.1 ImmunoSite Technologies Company Information
11.13.2 ImmunoSite Technologies Non-Clinical Testing Service Product Offered
11.13.3 ImmunoSite Technologies Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ImmunoSite Technologies Main Business Overview
11.13.5 ImmunoSite Technologies Latest Developments
11.14 Ascendant Engineering Solutions
11.14.1 Ascendant Engineering Solutions Company Information
11.14.2 Ascendant Engineering Solutions Non-Clinical Testing Service Product Offered
11.14.3 Ascendant Engineering Solutions Non-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Ascendant Engineering Solutions Main Business Overview
11.14.5 Ascendant Engineering Solutions Latest Developments
12 Research Findings and Conclusion